Moleculin Biotech, Inc. - MBRX

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q3 2026 · Q2 2026
Value (USD)
Total reported value ($000)
$511K
QoQ value delta ($000)
$0 (0.0%)
Implied price effect (QoQ)
+0.02%
Shares
Total shares
185,741
QoQ shares delta
-43 (-0.02%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (MBRX)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q3 2026)

Top 25 only Full list
Partial Q3 2026 data: 2 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
Manager Value ($000) Shares % of 13F
GEODE CAPITAL MANAGEMENT, LLC 131 47,252 0.0%
VANGUARD CAPITAL MANAGEMENT LLC 117 42,215 0.0%
VANGUARD FIDUCIARY TRUST CO 83 29,883 0.0%
XTX Topco Ltd 64 22,942 0.0%
MORGAN STANLEY 55 20,036 0.0%
Rockefeller Capital Management L.P. 41 15,000 0.0%
Tower Research Capital LLC (TRC) 9 3,514 0.0%
CITIGROUP INC 7 2,674 0.0%
BARCLAYS PLC 1 621 0.0%
JONES FINANCIAL COMPANIES LLLP 1 360 0.0%
BlackRock, Inc. 1 491 0.0%
EFG International AG 1 434 0.0%
WELLS FARGO & COMPANY/MN 0 200 0.0%
DANSKE BANK A/S 0 2 0.0%
OSAIC HOLDINGS, INC. 0 1 0.0%
CVA Family Office, LLC 0 1 0.0%
NFSG Corp 0 114 0.0%
Caitong International Asset Management Co., Ltd 0 1 0.0%